<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ruleSet xmlns="http://semanticbits.com/rules/brxml"><id>d2fc3bc6-8e04-4a41-83b1-d1dff504b1ff</id><name>gov.nih.nci.cabig.caaers.rules.sponsor.study.n0543__a_phase_ii_trial_of_pharmacogenetic_based_dosing_of_irinotecan__oxaliplatin__and_capecitabine_as_first_line_therapy_for_advanced_small_bowel_adenocarcinoma.cancer_therapy_evaluation_program.sae_reporting_rules</name><description>SAE Reporting Rules</description><subject>Sponsor defined rules for a study||Cancer Therapy Evaluation Program||N0543, A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma</subject><coverage>Enabled</coverage><import>gov.nih.nci.cabig.caaers.domain.*</import><rule id="b4d2e9df-0d28-486f-bfa6-f3bf771792a7"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Investigational new drug? " grammer-postfix="(Commercially Available Agent Only)" field-name="StudyAgentIndIndicator" display-uri="undefined"><literal-restriction evaluator="isOnly" display-uri="is "><value>false</value><readable-value>No </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyAgent','investigationalNewDrugIndicator','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="&gt;=" display-uri="is greater than or equal to "><value>4</value><readable-value>Grade 4</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>N0543, A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","N0543, A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma","==")</expression></column></condition><action>Commercial Intervention 24 Hour SAE Notification</action><action>Commercial Intervention 3 Day Report</action><readableAction>Commercial Intervention 24 Hour SAE Notification</readableAction><readableAction>Commercial Intervention 3 Day Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.n0543__a_phase_ii_trial_of_pharmacogenetic_based_dosing_of_irinotecan__oxaliplatin__and_capecitabine_as_first_line_therapy_for_advanced_small_bowel_adenocarcinoma.cancer_therapy_evaluation_program.sae_reporting_rules" name="Rule-1" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/n0543__a_phase_ii_trial_of_pharmacogenetic_based_dosing_of_irinotecan__oxaliplatin__and_capecitabine_as_first_line_therapy_for_advanced_small_bowel_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Investigational new drug? is  'No ' (Commercially Available Agent Only)</line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is greater than or equal to  'Grade 4' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line></readableRule></rule><rule id="8a87402f-9973-4659-8541-1b5348a8ca62"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Severity " grammer-postfix="" field-name="grade" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>3</value><readable-value>Grade 3</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Grade','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Hospitalization or Prolonged Hospitalization " grammer-postfix="" field-name="hospitalization" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>1</value><readable-value>Yes</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Hospitalization','code','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Attribution " grammer-postfix="" field-name="attributionSummary" display-uri="undefined"><literal-restriction evaluator="!=" display-uri="is not "><value>UNRELATED</value><value>UNLIKELY</value><readable-value>Unlikely,Unrelated,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,'gov.nih.nci.cabig.caaers.domain.Attribution','name','runTimeValue','runTimeOperator')</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.AdverseEvent" identifier="adverseEvent" display-uri="Adverse Event"><field-constraint grammer-prefix=" Adverse Event " grammer-postfix="expected " field-name="expectedness" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>false</value><readable-value>is not </readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(adverseEvent,null,'expectedness','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>N0543, A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","N0543, A Phase II Trial of Pharmacogenetic-Based Dosing of Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy for Advanced Small Bowel Adenocarcinoma","==")</expression></column></condition><action>Commercial Intervention 7 Day AdEERS Report</action><readableAction>Commercial Intervention 7 Day AdEERS Report</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.n0543__a_phase_ii_trial_of_pharmacogenetic_based_dosing_of_irinotecan__oxaliplatin__and_capecitabine_as_first_line_therapy_for_advanced_small_bowel_adenocarcinoma.cancer_therapy_evaluation_program.sae_reporting_rules" name="Rule-2" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/n0543__a_phase_ii_trial_of_pharmacogenetic_based_dosing_of_irinotecan__oxaliplatin__and_capecitabine_as_first_line_therapy_for_advanced_small_bowel_adenocarcinoma/cancer_therapy_evaluation_program</path><metaData name="sae_reporting_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Severity is not  'Grade 3' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Hospitalization or Prolonged Hospitalization is  'Yes' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Attribution is not  'Unlikely'  or 'Unrelated' </line><line>AND</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Adverse Event is  'is not ' expected </line></readableRule></rule></ruleSet>

